Recent Finacing
Recent Raise
Qlaris Bio is a clinical-stage biotech developing QLS-111, a KATP-channel modulator to lower intraocular pressure by targeting episcleral venous pressure, currently in multiple U.S. Phase II glaucoma trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Qlaris Bio.
